Navigation Links
New breast cancer risk model quantifies the impact of risk reduction

How much can a woman lower her risk of breast cancer by losing weight, drinking less, or exercising more? A study published online June 24 in the Journal of the National Cancer Institute describes a new model to estimate the impact of these lifestyle changes on absolute breast cancer risk, suggesting risk reductions that could translate into a substantial number of prevented cancers across an entire population.

Breast cancer risk models are widely used to estimate a woman's chances of developing the disease. These are based on non-modifiable risk factors such as age and family history of breast cancer and on modifiable lifestyle factors. But there is little information on how much lifestyle changes would reduce absolute breast cancer risk in individuals and in the population.

In this study, Elisabetta Petracci, Ph.D., and Mitchell Gail, M.D., Ph.D., at the National Cancer Institute and colleagues developed the model using data from an Italian case-control study with more than 5,000 women. Their model includes five risk factors that are difficult or impossible to modify (reproductive characteristics, education, occupational activity, family history, and biopsy history) and three risk factors that are more modifiable (alcohol consumption, leisure physical activity, and body mass index).

The model predicted that changes in the more modifiable risk factors would reduce the absolute risk of developing breast cancer by quantifiable amounts. The average 20-year reduction in absolute risk among women aged 65 was 1.6% in the entire population; 3.2% among women with a positive family history of breast cancer; and 4.1% among women with the most non-modifiable risk factors.

The authors note that the results may help in designing programs aimed at encouraging lifestyle changes. For instance, in a general population of 1 million women, even a 1.6% absolute risk reduction amounts to 16,000 fewer cases of cancer. In contrast, a 3.2% reduction in a higher-risk group--postmenopausal women with a family history--amounts to only 2,560 fewer cases, according to the model.

The authors conclude that these results give perspective on the potential public health impact of reducing exposure to such risk factors and could be useful for designing studies to test the efficacy of prevention programs.

In an accompanying editorial, Kathy J. Helzlsouer, M.D., of Mercy Medical Center in Baltimore writes that the study "provides extremely important information relevant to counseling women on how much risk reduction they can expect by changing behaviors, and also highlights the basic public health concept that small changes in individual risk can translate into a meaningful reduction in disease in a large population." However, she also points out that these estimates are based on optimistic assumptions of changes in behaviors and that the results do not necessarily apply to people in other countries, such as the U.S., where breast cancer rates among older women are much higher than in Italy.

"These differences, however, serve to emphasize the need for models such as these to be created on the basis of local data to provide the best estimates of risk to aid decision making, whether for the individual or the population in public health settings," she writes.


Contact: Caroline McNeil
Journal of the National Cancer Institute

Related medicine news :

1. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
2. Low forms of cyclin E reduce breast cancer drugs effectiveness
3. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
4. For Some Breast Cancer Patients, Shorter Radiation Works Well
5. Short-term radiation therapy successful on breast cancer
6. Few Women at High Risk for Breast Cancer Take Tamoxifen
7. Hormone May Prevent Aggressive Breast Cancer
8. MSU researcher linking breast cancer patients with alternative therapies
9. MRI May Not Add Value to Routine Breast Cancer Care
10. Breast Cancer Stats Differ Racially Despite Similar Mammogram Rates
11. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... For the ... is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic ... the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North America. ...
(Date:12/1/2015)... ... ... McLean, VA., December 1, 2015 - Octo Consulting Group, ... development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services Directorate. ... as well as operations and sustainment support to the NGA’s Agile Web Presence ...
(Date:12/1/2015)... ... ... XTC Semifinals 2016 - CES, Las Vegas, Nevada - Extreme ... 2016, the world’s largest Consumer Electronic Show, where they will present to a panel ... Pacific Investments Veronica Serra, and venture capitalist Tim Draper among many other top names ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Arash ... Modern Man for 2015. , Angeleno Magazine is a division of Modern ... in 1994, Modern Luxury includes more than 50 magazine titles across 15 major ...
(Date:11/30/2015)... ... 2015 , ... Olympic Gold Medalists and Celebrity Moms Dara ... various categories through traditional and social media marketing campaigns and other branding initiatives. ... Medal Moms who can connect with today’s most important consumer: mothers. In addition ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... -- ) has announced ... Market 2015 - Forecast to 2020" report ... has announced the addition of the "Drug ... report to their offering. --> ... the addition of the "Drug Delivery Technology ...
(Date:12/1/2015)... Sweden , December 1, 2015 ... Cancer Study Group (IBCSG, Bern ) and ... to be part of a state of the art trial, ... --> --> The study, ... treated with anti-hormonal therapy in combination with palbociclib, a cancer ...
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 /PRNewswire/ ... its wholly-owned UK subsidiary Proximagen Ltd., today announced a ... oral small molecule inhibitor of Vascular Adhesion Protein 1 ... the treatment of inflammatory disease. The VAP-1 inhibitor is ... --> --> Under the terms of ...
Breaking Medicine Technology: